Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 192

1.

[Discontinuation of antidepressant serotonergic antidepressant].

Andersen CL, Videbech P.

Ugeskr Laeger. 2010 Jan 25;172(4):296-8. Danish.

PMID:
20105399
2.

[Severe withdrawal symptoms with fever during paroxetine tapering off].

Peeters FP, Zandbergen J.

Ned Tijdschr Geneeskd. 1999 Jul 3;143(27):1429-31. Dutch.

PMID:
10422558
3.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
4.

Adverse events after the abrupt discontinuation of paroxetine.

Dominguez RA, Goodnick PJ.

Pharmacotherapy. 1995 Nov-Dec;15(6):778-80.

PMID:
8602387
5.

Antidepressant discontinuation: a review of the literature.

Lejoyeux M, Adès J.

J Clin Psychiatry. 1997;58 Suppl 7:11-5; discussion 16. Review.

6.

Selective serotonin reuptake inhibitor. Discontinuation syndrome.

Finfgeld DL.

J Psychosoc Nurs Ment Health Serv. 2002 Dec;40(12):14-8.

PMID:
12491870
7.

Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.

Markowitz JS.

J ECT. 1998 Mar;14(1):55. No abstract available.

PMID:
9661096
8.

[Delirium during withdrawal of venlafaxine].

van Noorden MS, Vergouwen AC, Koerselman GF.

Ned Tijdschr Geneeskd. 2002 Jun 29;146(26):1236-7. Dutch.

PMID:
12132141
9.

[Withdrawal syndrome after the use of serotonin reuptake inhibitors].

Fagan M.

Tidsskr Nor Laegeforen. 2000 Mar 20;120(8):913-4. Norwegian.

10.

[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].

Bryois C, Rubin C, Zbinden JD, Baumann P.

Praxis (Bern 1994). 1998 Mar 4;87(10):345-8. Review. French.

PMID:
9545842
11.

[Venlafaxine withdrawal syndrome: report of six cases and review of the literature].

Pinzani V, Giniès E, Robert L, Peyrière H, Abbar M, Blayac JP.

Rev Med Interne. 2000 Mar;21(3):282-4. Review. French.

PMID:
10763190
12.

Serotonin syndrome in the elderly after antidepressive monotherapy.

Fischer P.

J Clin Psychopharmacol. 1995 Dec;15(6):440-2. No abstract available.

PMID:
8748434
13.

Shock-like sensations during venlafaxine withdrawal.

Reeves RR, Mack JE, Beddingfield JJ.

Pharmacotherapy. 2003 May;23(5):678-81.

PMID:
12741444
14.

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.

Judge R, Parry MG, Quail D, Jacobson JG.

Int Clin Psychopharmacol. 2002 Sep;17(5):217-25.

PMID:
12177584
15.

Venlafaxine withdrawal syndrome.

Sabljić V, Ružić K, Rakun R.

Psychiatr Danub. 2011 Mar;23(1):117-9.

16.

Do your patients suffer from excessive yawning?

Gutiérrez-Alvarez AM.

Acta Psychiatr Scand. 2007 Jan;115(1):80-1.

PMID:
17201870
17.

Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.

Zajecka J, Fawcett J, Amsterdam J, Quitkin F, Reimherr F, Rosenbaum J, Michelson D, Beasley C.

J Clin Psychopharmacol. 1998 Jun;18(3):193-7.

PMID:
9617977
18.

Antidepressant use during pregnancy. FPIN’s clinical inquiries.

Patel BN, Beste J, Blackwell JC.

Am Fam Physician. 2011 May 15;83(10):1211-5. No abstract available.

19.

An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram.

Markowitz JS, DeVane CL, Liston HL, Montgomery SA.

Int Clin Psychopharmacol. 2000 Nov;15(6):329-33.

PMID:
11110008
20.

Acute adverse cutaneous reaction after the concomitant use of venlafaxine and orphenadrine citrate plus paracetamol in a depressed patient.

Papadimitriou GN, Theleritis CG, Papageorgiou CC, Kalogeromitros D, Syrigou E, Gregoriou S, Rabavilas AD.

J Eur Acad Dermatol Venereol. 2006 Sep;20(8):1019. No abstract available.

PMID:
16922966

Supplemental Content

Support Center